fbpx
  1. Home
  2. »
  3. Daily Research Pulse
  4. »
  5. Daily Research Pulse for February 10, 2023

Daily Research Pulse for February 10, 2023

Facebook
Twitter
LinkedIn
Print
Summary: The US FDA has withdrawn emergency-use authorization for bebtelovimab and sotrovimab due to their ineffectiveness against some SARS-CoV-2 strains. No information is available on their use during breastfeeding, but it is likely that the amount in milk would be very low and partially destroyed in the infant's gastrointestinal tract.
  • Bebtelovimab: The US FDA has withdrawn emergency-use authorization for bebtelovimab due to its ineffectiveness against some SARS-CoV-2 strains. No information is available on the use of bebtelovimab during breastfeeding, but it is likely to be present in small amounts and partially destroyed in the infant’s gastrointestinal tract.
  • Sotrovimab: Sotrovimab, a monoclonal antibody directed against SARS-CoV-2, has had its emergency use authorization withdrawn in the US due to poor activity against some Omicron strains. No information is available on its use during breastfeeding, but it is likely to be present in very low amounts and partially destroyed in the infant’s gastrointestinal tract.
  • Etesevimab and Bamlanivimab: The distribution of etesevimab and bamlanivimab was stopped in June 2021 due to lack of efficacy against COVID-19 variants. No information is available on their use during breastfeeding, but it is likely that the amount in milk would be very low.
  • The role of COVID-19 in myopathy: incidence, causes, treatment, and prevention: Myopathy is a muscle disorder that can be caused by genetics, medication, or inflammation. Recently, an increase in cases of myopathy has been seen due to the SARS-CoV-2 virus and the drugs used for its treatment.
  • Neurological Manifestations of Long COVID: A Single-Center One-Year Experience: This is a retrospective observational study of neurological manifestations of long COVID in patients referred to a neurological long COVID outpatient clinic from January 2021 to December 2021. Treatments and investigations were prescribed on an individual basis.
  • Lessons from the coronavirus disease 2019 pandemic in schizophrenia: a review: This review synthesized data on the increased risk of infection and mortality, the impact of the pandemic and lockdowns on psychiatric care, vaccination policies, and unwillingness to vaccinate in patients with schizophrenia, as well as the rates of vaccination.
  • Frequency and survival of Covid associated mucormycosis patients at tertiary care hospitals in Pakistan: A retrospective observational study: This study aims to observe the frequency and survival of Covid-associated mucormycosis patients in Pakistan during 2020-2021.
  • Accommodative insufficiency in post-COVID-19 case with refractive error: This case report describes the diagnosis, management, and treatment of accommodative insufficiency as a possible postinfectious manifestation of COVID-19 in a 22-year-old patient who presented with blurring of distance and near vision with a frontal headache after prolonged near work.
  • QUALITY OF LIFE AFTER CORONAVIRUS DISEASE 2019 HOSPITALIZATION AND REHABILITATION NEEDS: This is a prospective cohort study of 92 adults in Greece who were discharged from the Infectious Disease Unit of a third-level hospital after being hospitalized with COVID-19. The study aims to assess the long-term functional status of these patients and the utilization of rehabilitation services nationwide.

Daily News Pulse for March 13, 2023

Summary: Princeton students have seen an overall improvement in course satisfaction since the start of the COVID-19 pandemic. In Japan, many people are still wearing masks despite the government’s easing of guidelines.

Daily Research Pulse for March 13, 2023

Summary: A systematic review examines the prevalence of nurses and physicians leaving their positions in European hospitals and the factors influencing job retention among them. Researchers found that 31.4% of hospitalized patients with cardiac problems and suspected COVID-19 had PTSD during waves 2-5 of the pandemic.

Daily News Pulse for March 10, 2023

Summary: A pilot study by Brigham and Women’s Hospital found that nasal administration of the anti-CD3 monoclonal antibody Foralumab can modulate T cell inflammatory responses in COVID-19. The Washington State Department of Health is ending its free at-home testing program Say Yes! COVID Test on May 11. California Governor Gavin Newsom has tested positive for COVID-19 after a personal trip to Baja California.

Daily Research Pulse for March 10, 2023

Summary: Researchers examined the clinical, laboratory, and cardiac indicators of multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (Covid-19), and the experiences and behaviors of adults with positive SARS-CoV-2 test results or who were exposed to a confirmed case of COVID-19.

Daily News Pulse for March 09, 2023

Summary: California Governor Gavin Newsom tested positive for COVID-19 and will be in isolation for the next five days. After recovering from a mild case of COVID, many people have developed long-term gastrointestinal symptoms. The US House of Representatives held a public hearing to explore the origins of the virus.